Baxter International (BAX) Cash from Investing Activities (2009 - 2026)
Baxter International's (BAX) quarterly Cash from Investing Activities came in at -$133.0 million in Q1 2026, down 104.07% year-on-year from $3.3 billion in Q1 2025, and up 96.2% on a QoQ basis from -$3.5 billion in Q4 2025.
Baxter International (BAX) Cash from Investing Activities (2009 - 2026) Analysis & Trends
Baxter International (BAX) has 18 years of Cash from Investing Activities data on file, last reported at -$133.0 million in Q1 2026.
- On a quarterly basis, Cash from Investing Activities fell 104.07% year-over-year to -$133.0 million in Q1 2026; TTM through Mar 2026 was -$3.9 billion, a 241.0% decrease from a year earlier, with the FY2025 full-year figure at -$464.0 million, up 25.88% from the prior year.
- Cash from Investing Activities for Q1 2026 stood at -$133.0 million, up from -$3.5 billion in the prior quarter.
- Over the last five years, Cash from Investing Activities for BAX reached as high as $3.3 billion in Q3 2025 and fell as low as -$3.5 billion in Q2 2025.
- Historically, Cash from Investing Activities has averaged -$132.8 million across 5 years, with a median of -$157.0 million in 2024.
- Across the five-year window, Cash from Investing Activities plunged 16500.0% in 2024 and soared 3365.0% in 2025, its largest moves.
- Year by year, Cash from Investing Activities stood at $51.0 million in 2022, then plunged by 266.67% to -$85.0 million in 2023, then sank by 141.18% to -$205.0 million in 2024, then plunged by 1608.78% to -$3.5 billion in 2025, then soared by 96.2% to -$133.0 million in 2026.
- Per Business Quant data, the three most recent Cash from Investing Activities figures were -$133.0 million in Q1 2026, -$3.5 billion in Q4 2025, and $3.3 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.54 Bn | 121.33 Bn | 1.96 Bn | -26.60 Mn |
| 2 | Becton Dickinson | 44.82 Bn | 44.00 Bn | 2.15 Bn | -139.00 Mn |
| 3 | Alcon | 32.93 Bn | 31.28 Bn | 1.53 Bn | -218.00 Mn |
| 4 | Medline | 32.92 Bn | 30.68 Bn | 1.84 Bn | -96.00 Mn |
| 5 | Resmed | 29.48 Bn | 27.82 Bn | 890.98 Mn | -58.03 Mn |
| 6 | West Pharmaceutical Services | 23.40 Bn | 22.97 Bn | 329.20 Mn | -43.20 Mn |
| 7 | Solventum | 14.04 Bn | 13.48 Bn | 1.10 Bn | -77.00 Mn |
| 8 | Cooper Companies | 13.79 Bn | 13.65 Bn | 735.40 Mn | -90.00 Mn |
| 9 | Align Technology | 12.05 Bn | 10.99 Bn | 736.59 Mn | -131.58 Mn |
| 10 | Baxter International | 11.93 Bn | 9.92 Bn | 891.00 Mn | -133.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -133.00 Mn |
| Mar 31, 2026 | -133.00 Mn |
| Dec 31, 2025 | -3.50 Bn |
| Dec 31, 2025 | -3.50 Bn |
| Sep 30, 2025 | 3.28 Bn |
| Sep 30, 2025 | 3.28 Bn |
| Jun 30, 2025 | -3.50 Bn |
| Jun 30, 2025 | -3.50 Bn |
| Mar 31, 2025 | 3.27 Bn |
| Mar 31, 2025 | 3.27 Bn |
| Dec 31, 2024 | -205.00 Mn |
| Dec 31, 2024 | -205.00 Mn |
| Sep 30, 2024 | -164.00 Mn |
| Sep 30, 2024 | -164.00 Mn |
| Jun 30, 2024 | -157.00 Mn |
| Jun 30, 2024 | -157.00 Mn |
| Mar 31, 2024 | -100.00 Mn |
| Mar 31, 2024 | -100.00 Mn |
| Dec 31, 2023 | -85.00 Mn |
| Dec 31, 2023 | -85.00 Mn |